Alzheimer's disease and geriatric eye diseases in the aspect of amyloid genesis

Arkhiv Patologii

Volumn 75, Issue 2, 2013, Pages 37-42

  Ermilov, V V ^a   Tyurenkov, I N ^a   Nesterova, A A ^a   Zagrebin, V L ^a  

^a VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Age related macular regeneration; Alzheimer's disease; Amyloid genesis; Ocular amyloidosis; Transgenic animal models

Indexed keywords

AMYLOID;

AGING; ALZHEIMER DISEASE; EYE DISEASE; FEMALE; HUMAN; MALE; METABOLISM; PATHOLOGY; REVIEW;

AGING; ALZHEIMER DISEASE; AMYLOID; EYE DISEASES; FEMALE; HUMANS; MALE;

EID: 84884746239     PISSN: 00041955     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Skovronsky D.M., Lee V.M., Trojanowski J.Q. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Ann. Rev. Pathol. 2006; 1: 151-70.
2. Sipe J.D., Benson M.D., Buxbam J.N. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid. 17 (3-4): 101-4.
3. Parnell M., Guo L., Abdi M., Cordeiro M.F. Ocular manifestations of Alzheimer's disease in animal models. Int. J. Alzheimer's Dis. 2012; 39: 187-204.
4. Ning A., Cui J., To E., Ashe K.H., Matsubara J. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest. Ophthalmol. Vis. Sci. 2008; 49 (11): 5136-43.
5. has J.M., Luibl V., Johnson L. V., Kayed R., Wetzel R., Glabe C.G. et al. Soluble and Mature Amyloid Fibrils in Drusen Deposits. Invest. Ophthalmol. Vis. Sci. 2010; 51 (3): 1304-10.
6. Ohno-Matsui K. Parallel findings in age-related macular degeneration and Alzheimer's disease. Prog. Retin. Eye Res. 2011; 30 (4): 217-38.
7. Berisha F, Feke G.T., Trempe C.L., McMeel J.W., Schepens C.L. Retinal abnormalities in early Alzheimer's disease. Invest. Ophthalmol. Vis. Sci. 2007; 48 (5): 2285-9.
8. Chiu K., Chan T.F., Wu A., Leung 1. Y., So K.F., Chang R.C. Neu-rodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina? Invest. Ophthalmol. Vis. Sci. 2012; 34(3): 633-49.
9. McKinnon S.J. Glaucoma: ocular Alzheimer's disease? Front. Biosci. 2003; 8: 1140-56.
10. Guo L., Salt T.E., Luong V., Wood N., Cheung W., Maass A. et al. Targeting amyloid-beta in glaucoma treatment. Proc. Natl. Acad. Sci. USA. 2007; 104(33): 13444-9.
11. Gehrs K.M., Anderson D.H., Johnson L.V., Hageman G.S. Age-related macular degeneration - emerging pathogenetic and therapeutic concepts. Ann. Med. 2006; 38: 450-71.
12. Luibl K, Isas J.M., Kayed R., Glabe C.G., Langen R., Chen /Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J. Clin. Invest. 2006; 116: 378-85.
13. Ermilov V., Makhonina O. The role of retinal pigment epithelium cells in amyloidogenesis of senile local eye amyloidosis with age-related macular degeneration. In: 23rt European congress of pathology. 27 August - 1 September 2011. Helsinki: 38-41.
14. Al-Hussaini H., Schneiders M., Lundh P., Jeffery G. Drusen are associated with local and distant disruptions to human retinal pigment epithelium cells. Exp. Eye Res. 2009; 88: 610-2.
15. Crabb J. W., Miyagi M., Gu X. el al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Nat. Acad. Sci. USA. 2002; 99: 14682-7.
16. VirgilAlfaro III D., Liggett P.E., Mieler W.E, Quiroz-Mercado Hugo, lager R.D., Tano Yasuo. Age-related macular degeneration. Baltimore: Williams & Wilkins; 2006. 550 p.
17. Blanks J.C., Torigoe Y, Hinton D.R., Blanks R.H. Retinal degeneration in the macula of patients with Alzheimer's disease. Ann. N. Y. Acad. Sci. 1991; 640: 44-6.
18. Hooper C. Y, Guymer R.H. New treatments in age-related macular degeneration. Clin. Exp. Ophthalmol. 2003; 31 (5): 376-91.
19. Kinnunen K., Petrovski G., Moe M.C., Berta A., Kaarniranta K. Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol. 2012; 90 (4): 299-309.
20. Ramkumar H.L., Zhang J., Chan C.C. Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog. Retin. Eye Res. 2010; 29 (3): 169-90.
21. Perez S.E., Lumayag S., Kovacs B., Mufson E.J., Xu S. Beta-amyloid deposition and functional impairment in the retina of the AP-Pswe/PSlDeltaE9 transgenic mouse model of Alzheimer's disease. Invest. Ophthalmol. Vis. Sci. 2009; 50 (2): 793-800.
22. Liu B., Rasool S., Yang Z, Glabe C.G., Schreiber S.S., Ge J. et al. Amyloid-peptide vaccinations reduce (beta)-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice. Am. J. Path. 2009; 175 (5): 2099-110.
23. Kaarniranta K., Salminen A., Haapasalo A., Soininen H., Hiltunen M. Age-related macular degeneration (AMD): Alzheimer's disease in the eye? J. Alzheimer's Dis. 2011; 24 (4): 615-31.
24. Ding J.D., Johnson L. V., Herrmann R., Farsiu S., Smith S.G., Gro-elle M. et al. Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc. Natl. Acad. Sci. USA. 2011; 108 (28): 279-87.
25. Iseri P.K., Altinas O., Tokay T., Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J. Neuroophthalmol. 2006; 26(1): 18-24.
26. Ding J.D., Lin J., Mace B.E., Herrmann R., Sullivan P., Bowes Rickman C. et al. Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model. Vis. Res. 2008; 48 (3): 339-45.
27. Dodel R., Balakrishnan K., Keyvani K., Deuster O., Nejf E, Andrei-Selmer L.C. et al. Naturally occurring autoantibodies against P-Amyloid. J. Neurosci. 2011; 31 (15): 5847-54.
28. Bach J. P., Dodel R. Naturally occurring autoantibodies against P-Amyloid. Adv. Exp. Med. Biol. 2012; 750: 91-9.
29. Woodhouse A., Dickson T., Vickers J. Vaccination strategies for Alzheimer's disease: A new hope? Drugs & Aging. 2007; 24 (2): 107-19.
30. Donoso L.A., Vrabec T., Kuivaniemi H. The role of complement Factor H in age-related macular degeneration: a review. Surv. Ophthalmol. 2010; 55 (3): 227-46.
31. Quan Y.L., Zhou A. Y, Feng Z.H. Association between complementary factor H Y402H polymorphisms and age-related macular degeneration in Chinese: Systematic review and meta-analysis. Int. J. Ophthalmol. 2012; 5 (2): 242-6.
32. Bird A.C. Therapeutic targets in age-related macular disease. J. Clin. Invest. 2010; 120 (9): 3033-41.